As of January 22, 2025, Corvus Pharmaceuticals (CRVS) has a market cap of $0.35 billion USD. According to our data, Corvus Pharmaceuticals is ranked No.6515 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.35 B |
1.68%
|
Dec 31, 2024 | $0.34 B |
203.98%
|
Dec 29, 2023 | $0.11 B |
107.06%
|
Dec 30, 2022 | $54.62 M |
-64.73%
|
Dec 31, 2021 | $0.15 B |
-32.30%
|
Dec 31, 2020 | $0.23 B |
-34.56%
|
Dec 31, 2019 | $0.35 B |
48.23%
|
Dec 31, 2018 | $0.24 B |
-64.58%
|
Dec 29, 2017 | $0.67 B |
-27.55%
|
Dec 30, 2016 | $0.92 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Bristol-Myers Squibb
BMY
|
$115.77 B |
0.000 M
|
USA
|
Merck
MRK
|
$242.01 B |
0.005 M
|
USA
|
Pfizer
PFE
|
$147.43 B |
0.004 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Novartis
NVS
|
$196.25 B |
0.003 M
|
Switzerland
|
Johnson & Johnson
JNJ
|
$349.71 B |
-0.006 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
AbbVie
ABBV
|
$298.91 B |
0.013 M
|
USA
|
Eli Lilly
LLY
|
$677.80 B |
-0.006 M
|
USA
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Market Cap | = | CRVS Stock Price | * | CRVS Shares Outstanding |
= | $5.44 | * | 64.26 M | |
= | $0.35 B |